Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
Products
Antibodies
ELISA and Assay Kits
Research Areas
Infectious Disease
Resources
Purchasing
Reference Material
Contact Us
Locations
Orders Processing,
Shipping & Receiving,
Warehouse
2 Shaker Rd Suites
B001/B101
Shirley, MA 01464
Production Lab
Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036
Telephone Numbers
Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565
Contact Us
Additional Contact Details
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
| Catalog Number | Size | Price |
|---|---|---|
| LS-G26430-10 | 10 µg | $265 |
| LS-G26430-50 | 50 µg | $315 |
| LS-G26430-100 | 100 µg | $365 |
Human CSF3 / G-CSF Protein (Recombinant TRX-6His, N-terminus) (Thr31-Pro207) - LS-G26430
Human CSF3 / G-CSF Protein (Recombinant TRX-6His, N-terminus) (Thr31-Pro207) - LS-G26430
Description:
CSF3 / G-CSF Protein LS-G26430 is a Recombinant Human CSF3 / G-CSF produced in E. coli Thr31-Pro207 with TRX-6His, N-terminus tag(s). For Research Use Only
Toll Free North America
206-374-1102
206-374-1102For Research Use Only
Overview
Description:
CSF3 / G-CSF Protein LS-G26430 is a Recombinant Human CSF3 / G-CSF produced in E. coli Thr31-Pro207 with TRX-6His, N-terminus tag(s). For Research Use Only
Specifications
Type
Recombinant Protein
Target
CSF3 / G-CSF
Synonyms
CSF3 | C17orf33 | G-CSF | GCSF | Pluripoietin | CSF3OS | Lenograstim
Species
Human
Modifications
Unmodified
Conjugations
Unconjugated
Tag
TRX-6His, N-terminus
Region
Thr31-Pro207
Predicted Molecular Weight
36.5 kDa
Expression System
E. coli
Source Species
E. coli
Purification
Greater than 95% by SDS-PAGE
Usage Summary
Recommended applications: ELISA, Western blotting, Dot Blotting, Immunogen, Protein Array
Bio-Activity
Not Tested
Endotoxin
Not Tested
Presentation
Sterile solution in PBS, pH 7.4, 25% Glycerol.
Storage
Short term: Store at 4 °C for up to 2 weeks. Long term: Store lyophilized at -20 °C in a dessicator or aliquot and store at -80 °C. Avoid freeze/thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
About CSF3 / G-CSF
Publications (0)
Customer Reviews (0)
Images
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
SDS-PAGE under reducing conditions and visualized by Coomassie blue staining
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
SDS-PAGE under reducing conditions and visualized by Coomassie blue staining
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
SDS-PAGE under reducing conditions and visualized by Coomassie blue staining
Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis
SDS-PAGE under reducing conditions and visualized by Coomassie blue staining
Popular CSF3 / G-CSF Proteins
Source:
E. coli
Tag:
6His-SUMO, N-terminus
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/29/2024
Date Requested: 4/29/2024
